Ketamine Shows Promise for Treatment-Resistant Depression in Clinical Trials

New studies suggest ketamine may be more effective than traditional therapies, but results are mixed and further research is needed.

A mid-stage trial found slow-release ketamine pills safe but only effective at the highest dose.
Nearly 60% of participants in the ketamine trial dropped out due to lack of efficacy.
Ketamine may be more beneficial for outpatients and those with moderate symptoms compared to electroconvulsive therapy (ECT).
Patients with higher BMI showed better responses to ketamine treatment.
Further studies are required to validate these findings and guide personalized treatment plans.